Abstract-Although 17␤-estradiol (E2) is protective in experimental models of myocardial and brain ischemia, its effect on skin ischemia remains unknown. Here, we assessed the protective effect of E2 in a mouse model of skin ischemia, mimicking the surgery of skin flaps. Whereas necrosis appeared in the half portion of the skin flap within 1 week after surgery in ovariectomized mice, it was reduced up to 10-fold when mice were pretreated with E2, at least 3 days before the surgery. The beneficial effect of E2 appeared to be attributable to an increase in skin survival, revealed by measuring viability of ex vivo explants and enhancement of the antiapoptotic Bcl-2 protein expression in vivo. This protective effect on the skin contributed to the protection of the vascular network and facilitated reperfusion, which was found to be accelerated in ovariectomized E2-treated mice, whereas hemorrhages were observed in untreated mice. E2 also increased expression of fibroblast growth factor-2 isoforms in the skin and circulating vascular endothelial growth factor in the serum. Finally, this protective effect of E2 was abolished in estrogen receptor-deficient mice (ER␣ Ϫ/Ϫ ) but maintained in chimeric mice reconstituted with ER␣-deficient bone marrow, indicating dispensable action of E2 in bone marrow-derived cells. This protective effect of E2 was mimicked by treatment with tamoxifen, a selective estrogen receptor modulator. In conclusion, we have demonstrated for the first time that E2 exerts a major preventive effect of skin flap necrosis through a prevention of ischemic-induced skin lesions, including those of the vascular network, which contributes to accelerate the reperfusion of the skin flap. 
S
kin flaps are frequently used in plastic and reconstructive surgery. However, necrosis represents a major complication that may require secondary surgical interventions, generate multiple infections, and delay future treatments. Necrosis is caused by severe ischemia, resulting from impaired arterial inflow, especially in the distal part of the flap. Therapeutic angiogenesis by local administration of angiogenic growth factors fibroblast growth factor (FGF)-2 1 and vascular endothelial growth factor (VEGF), 2 and a combination of these growth factors, 3 have been successfully tested to enhance blood perfusion in affected tissues, decreasing the extent of flap necrosis. However, the safety of this approach remains controversial, 4 and no efficient therapy is currently available.
Estrogens appear to be attractive candidates, because 17␤-estradiol (E2) exerts protective effects in various animal models of cardiac, brain, and hindlimb ischemia [5] [6] [7] by favoring angiogenesis, limiting endothelial dysfunction, and exerting inflammatory and antiapoptotic effects. 8, 9 In elderly patients, E2 supplementation accelerates cutaneous wound healing. 10 The mechanisms underlying these changes involve an increase in transforming growth factor (TGF)-␤ 1 secretion 11 but also inhibition of the local inflammatory response by downregulating migration inhibitory factor, which contributes to enhance matrix deposition. 12 In the present work, we used a mouse model of cutaneous ischemia to investigate whether E2 can prevent necrosis after severe blood flow impairment. Whereas necrosis appeared in the distal portion of the skin flap within 1 week after surgery in ovariectomized mice, it was largely reduced or even totally prevented in E2-treated animals. We then analyzed the E2-induced mechanisms accounting for this protection, such as skin viability and kinetics of revascularization.
Materials and Methods

Animal Studies
Female C57BL/6J, FVB, hairless (SKH1) (Charles River Laboratories, Saint-Germain sur l'Arbresle, France), nude (NMRI) (Janvier, Le Genest St Isle, France) mice, and estrogen receptor ␣ knockout (ER␣KO) (described elsewhere 13 ) mice were ovariectomized at 5 weeks of age to suppress endogenous production of estrogens and implanted or not with pellets releasing either E2 (0.1 mg or 0.25 mg; 60-day release) or tamoxifen (5 mg; 60-day release) (Innovative Research of America, Sarasota, Fla). Skin flap surgery was performed 2 weeks later ( Figure 1A ). All mice were maintained under specific pathogen-free conditions in our animal facilities. Procedures were performed in accordance with the recommendations of the European Accreditation of Laboratory Animal Care and guidelines established by the National Institute of Medical Research (INSERM).
Administration of the nitric oxide synthase inhibitor N G -nitro-L-arginine methyl ester (L-NAME) (Sigma, Saint Quentin, France) (50 mg/kg per day in drinking water) was initiated 1 week before surgery.
Anti-TGF-␤ 1 /␤ 2 /␤ 3 or an isotype matched (IgG2b) control monoclonal antibody was injected 2 days before surgery and then twice a week. 14 
Ischemia Model and Necrosis Quantification
A U-shaped peninsular skin incision was created on the dorsal surface of anesthetized (ketamine [100 mg kg Ϫ1 ] and xylazine [10 mg kg Ϫ1 ]) mice. 15, 16 The skin was elevated from the underlying muscular bed and the 2 vascular pedicles arising from the lateral thoracic arteries (T) were sectioned ( Figure 1B) . To quantify necrosis, mice were photographed and necrosis area was measured by planimetry with the ImageJ software (NIH) ( Figure 1B ).
Bone Marrow Transplantation
Recipient C57BL/6 mice were lethally irradiated (9Gy, ␥-source) and reconstituted with bone marrow from either ER␣ ϩ/ϩ or ER␣ Ϫ/Ϫ donor 24 hours later.
Ex Vivo Viability Assays
Hairless female mice were ovariectomized and implanted or not with a pellet of E2. Two weeks later, dorsal skin samples were maintained in culture in DMEM medium (pH 7.4) supplemented with nonessential amino acids, 10% calf serum, 50 g/mL gentamicin, and E2 (Sigma-Aldrich; concentration, 10 Ϫ9 mol/L) or DMSO vehicle as control. Skin explants were incubated for 24 or 48 hours at 37°C in a 5% CO2 atmosphere. Viability of skin samples was determined by colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay as previously described. 17 
Skin Blood Perfusion and Angiography
Skin flap blood perfusion was assessed with a Laser Doppler Perfusion Imaging system (PeriScan PIM II Imager, Perimed AB, Järfälla, Sweden). Perfused skin vessels were visualized by angiography after intracardiac injection of fluorescein isothiocyanate dextran. Information regarding histological analysis, Western blot analysis and ELISA, transmission electron microscopy, and statistical analysis is available in the expanded Materials and Methods section in the online data supplement at http://circres.ahajournals.org.
Results
Protective Effect of E2 on Skin Flap Necrosis
To test the protective effect of E2 on skin flap necrosis, we standardized a model 16 to induce severe ischemia. In ovariectomized untreated C57BL/6 mice, severe and extended necrosis in the distal part of the flap (desquamation, alopecia, and scab formation) appeared maximal within 1 week after surgery ( Figure 1C ). In ovariectomized E2-treated mice, necrosis was largely reduced or even totally absent and wound healing at the incisions was accelerated. Quantitative analyses showed that necrosis in the untreated group accounted for 53.7Ϯ3.8% of the total flap area at its maximum on day 6, whereas in the E2-treated group, it represented only 3.8Ϯ2.6% (PϽ0.001). Similar results were obtained in FVB mice (48.1Ϯ8.2% in the untreated group versus 7.7Ϯ3.4% in E2-treated mice) (PϽ0.001) ( Figure 1D ). Mice were euthanized at the end of the protocol (day 21). Ovariectomized mice showed atrophied uteri (Ͻ20 mg), whereas E2-treated mice showed a significant increase in uterine weight (115Ϯ5 mg).
Effect of E2 Treatment on Skin Structure and Microscopic Lesions
Histological analysis was performed to qualify ischemic lesions. Ovariectomy increased both density and size of pilosebaceous units, which were the predominant proliferative structure in the absence of endogenous E2 (intense nuclear Ki-67 staining; Figure 2A ). E2 decreased skin thickness and favored a mucinous layer rich in glycosaminoglycans below the platysma muscle (detected by acid Alcian blue coloration; data not shown), as well as an arrest of follicle proliferation, as reported. 18 Necrosis was detected by microscopic examination earlier than by macroscopic examination ( Figure 2B , day 2 versus day 6). In E2-treated animals, necrosis extended to one-tenth the length of the flap on the distal part, whereas it affected not only the distal but also the medial portion of the flap in ovariectomized animals. The progression of degeneration toward necrosis was prominent in hair follicle cells (see Figure I in the online data supplement). The protective effect of E2 persisted in nude and hairless mice and was similar to that observed in wild type mice, ruling out a role of E2 on hair follicle proliferation as a significant mechanism for protection ( Figure 2C ).
Acute inflammation (vasodilation, rolling of neutrophils) was detectable 4 hours after surgery, but massive neutrophilic infiltrate appeared only on day 4 and was more severe in ovariectomized mice. Neutrophils were concentrated where fibrous scar tissue replaced the necrotic tissue (data not shown). Even if TGF-␤ 1 was shown to be involved in increase of wound healing by E2, we showed that administration of TGF-␤-neutralizing antibody did not have any major effect on necrosis extent (supplemental Figure II, A) . However, as previously reported, 19 blocking TGF-␤ delayed wound healing in ovariectomized mice (detectable from days 12 to 21).
E2 Improves Skin Survival
Tissue viability was assessed in ex vivo skin samples by following the activity of mitochondrial dehydrogenases (MTT assay) ( Figure 3A) . 17 Samples from ovariectomized mice showed 59.4Ϯ5.4% of MTT conversion after 24 hours of culture, whereas samples from E2-treated or intact female mice were still close to the maximum of viability (88.7Ϯ2.4% and 91.2Ϯ4.4%, respectively). After 48 hours of culture, skin viability was reduced in all groups but remained significantly higher in the E2-treated group (62.8Ϯ3.7%) and intact female skin (63.9Ϯ5.5%) compared to the untreated ovariectomized mice (31.3Ϯ4.6%). Addition of 10 Ϫ9 mol/L E2 in the culture medium increased not only skin samples viability from ovariectomized mice but also skin viability from both E2-treated and intact mice.
The expression of pro-and antiapoptotic molecules was detected in vivo in C57BL/6 skin flaps. As shown in Figure  3B , the expression of the antiapoptotic Bcl-2 protein was always low in ovariectomized mice as compared to E2-treated mice. It decreased slowly from day 0 to day 4 on the former, whereas a transient decrease was observed on day 2 on the latter. The procaspase-3 and Bcl-XL proteins were not affected by E2 treatment or by ischemia duration. Furthermore, the activated form of caspase-3 was not detected (data not shown).
E2 Accelerates Reperfusion of a Preserved Vascular Network
Histopathology indicated that vasodilatation occurs shortly after surgery (visible 4 hours after surgery; see supplemental Figure III , A). Because E2 is known to increase NO bioavailability, we investigated whether its protective effect against necrosis might be blunted by nitric oxide synthase inhibition. Pharmacological inhibition with N G -nitro-L-arginine methyl ester (L-NAME) had no effect on necrosis prevention by E2 (see supplemental Figure III, B) .
Evaluation of skin flap perfusion using color laser Doppler imaging showed that the severe ischemia induced by surgery was followed by a blood flow restoration starting from the proximal part of the flap ( Figure 4A ). In untreated mice, skin perfusion remained very low, even on days 6 and 8 and impaired perfusion was associated with necrosis. A quicker and more intense perfusion was observed in E2-treated mice, with an almost complete reperfusion on day 6. Quantification of blood flow then showed a significant higher reperfusion in the E2-treated group as compared to ovariectomized mice ( Figure 4B ). Figure 3 . Viability of the skin. A, Evaluation of ex vivo skin viability from hairless mice in culture: MTT assay was performed on dorsal skin samples harvested from intact female and ovariectomized mice treated or not with E2 immediately after animals were euthanized and after 24 or 48 hours of culture in DMEM supplemented or not with 10 Ϫ9 mol/L E2. Skin viability was expressed as a percentage of viability measured at time 0 (considered as 100%), as previously described. 17 Values are meansϮSEM from 4 skin samples. *PϽ0.05, ***PϽ0.001. B, Evaluation of in vivo expression of pro-and antiapoptotic factors in C57BL/6 mice. Bcl-2, Bcl-X L , and procaspase-3 protein expressions in the proximal area of skin flaps before surgery and at days 2 and 4 after surgery were determined by immunoblotting on protein extracts. ␤-Actin was used as a loading control. 
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Angiograms fitted well to laser Doppler images. On day 2, skin flap vascularization was generally absent, with no obvious difference between the 2 groups (data not shown). On day 4, examination of the vascular network indicated that remodeling of numerous arteriolar anastomoses present in the skin occurred on the top of the flap, in both groups, where pedicles were sectioned ( Figure 4C ). This remodeling allowed blow flow restoration, especially in E2-treated mice, in which reperfusion was almost complete. In untreated mice, perfusion was still missing in the most distal part of the flap and flap elevation showed severe hemorrhages ( Figure 4D ). Hemalum/eosin (H&E) staining ( Figure 4E ) clearly showed vessel thrombosis and erythrocyte extravasations in the dermis, especially in the middle zone of skin flaps. In contrast, a slight vascular congestion with minor hemorrhages was observed in E2-treated animals. Ki-67 immunohistochemistry indicated abundant proliferation of endothelial cells on day 4, without any significant difference between the 2 groups, even then TGF-␤ blocking antibody was administrated. Transmission electron microscopy confirmed the loss of vessel integrity in ovariectomized mice with presence of free erythrocytes in the tissue, whereas erythrocytes remained intravascular in E2-treated animals even if endothelial cells were damaged ( Figure 4F) .
Detection of cutaneous FGF-2 isoforms and plasmatic VEGF ( Figure 4G and 4H) indicated higher expression of both FGF-2 isoforms (all times) and VEGF (day 2) in E2-treated mice as compared to untreated mice. Additionally, in E2-treated animals, secreted FGF-2 isoform (supplemental Figure III , C) and circulating VEGF were further increased after surgery on day 2. Therefore, prevention of skin necrosis by E2 was associated with earlier reperfusion of a better preserved vascular network.
Influence and Duration of Dose of E2 Pretreatment
We evaluated exposure to different doses of E2, using untreated intact (endogenous E2) or treated intact mice (0.1-mg pellet) and ovariectomized mice given either a 0.1-or 0.25-mg pellet (releasing 80 and 200 g/kg per day, respectively), compared to untreated ovariectomized mice (dose, 0). There was no significant effect of the dose among the four groups impregnated with E2 ( Figure 5B ) (11.3Ϯ4.5% and 15.2Ϯ4.0% of necrosis in intact female mice treated or not with E2, respectively, compared to 11.9Ϯ2.6% and 9.3Ϯ2.3% in mice receiving 0.1 or 0.25 mg, respectively on day 8).
To reduce exposure to E2, the minimal time required to prevent skin necrosis was also evaluated. E2 treatment initiated 3 days before flap elevation conserved the protective effect, whereas abolition was observed when treatment was initiated the same day of surgery (Figure 5A ) (8.3Ϯ3.9%, and 41.1Ϯ5.6%, respectively, compared to 38.2Ϯ3.5% in ovariectomized animals).
These data indicated that a physiological estrogen exposure (ie, estrus cycle) or an exogenous E2 short treatment initiated 3 days before flap elevation were sufficient to obtain an optimal protection against necrosis.
Estrogen Receptor ␣ Mediates the Protective Effect of E2 but Is Dispensable in Bone Marrow-Derived Cells
Estrogens exert their biological effects through 2 different nuclear estrogen receptors (ERs), namely ER␣ 20 and ER␤, 21 which are expressed in various cell types, including endothelial cells, immune cells, and skin. ER␣ is known to mediate most of the E2 effects in the vascular system. 22 Surgery was performed in ER␣ Ϫ/Ϫ mice to evaluate the role of ER␣ in the protective effect of E2 on necrosis. Similar high rates of necrosis were obtained in ovariectomized ER␣ Ϫ/Ϫ mice treated or not with E2 (32.9Ϯ5.7% and 36.9Ϯ2.3%, respectively, on day 8) (Figure 6A ). To assess the contribution of bone marrow-derived cells, we grafted irradiated mice with ER␣ ϩ/ϩ or ER␣ Ϫ/Ϫ bone marrow. No significant difference was observed between the 2 groups of chimeric mice (ER␣ ϩ/ϩ versus ER␣ Ϫ/Ϫ ) ( Figure 6B ), but E2 treatment was as effective in ER␣ Ϫ/Ϫ chimeric mice as in control ER␣ ϩ/ϩ chimeric mice. These data indicated that the protective effect of E2 requires ER␣ expression, independently of its expression in bone marrow. Ϫ1 per day), respectively. B, Effect of E2 pretreatment duration on necrosis. E2 treatment was started 14 days or 3 days before the surgery or the day of the surgery (day 0). Percentages of necrosisϮSEM were given on day 8. **PϽ0.01; ***PϽ0.001; ns, not significant vs OVX-E2.
Effect of the Selective Estrogen Receptor Modulator Tamoxifen
Tamoxifen antagonizes the effect of E2 in breast cancer and is frequently administrated at the same time as breast reconstructive surgery but has some agonist actions on other tissues, for instance, uterus. Tamoxifen treatment 14 days before flap surgery significantly reduced the area of necrosis to 9.3Ϯ3.0% on day 8 compared to the placebo (38.2Ϯ3.5%), this protective effect being similar to that of E2 (13.2Ϯ2.9% on day 8, PϾ0.05) ( Figure 7A ). Histological analyses at the time of surgery showed that tamoxifen involved similar structural modifications than E2 ( Figure  7B ).
Discussion
Using a standardized mouse model of skin flap, we demonstrated for the first time, to our knowledge, that E2 efficiently protects against skin necrosis. We showed that ovarian cycle E2 amounts are sufficient to mediate this protective effect. Maximal protection was maintained with a 3-day pretreatment but abolished when initiated the day of surgery. Therefore, functional and/or structural changes in skin and/or vasculature seemed to be a prerequisite for the protective effect of E2. The similarity of the results obtained in different genetic backgrounds, including hairless mice, demonstrated the robustness of E2 effect. The protective effect of E2 was abolished in ER␣ Ϫ/Ϫ mice, indicating an additional role for ER␣ in skin necrosis prevention, which adds to its effects on reproduction, bone remodeling, vascular system. 22 The effect of E2 against skin ischemia involves preservation of skin viability, as demonstrated in ex vivo explants. Antiapoptotic effect of E2 has been extensively studied in ischemic brain 23, 24 and heart. 25, 26 E2 inhibits apoptosis in cultured keratinocytes by promoting Bcl-2 expression. 27 Our present data further indicated that E2 directly promotes skin survival, enhancing the antiapoptotic Bcl-2 expression in vivo. E2 treatment induces skin structural modifications, increasing the mucinous layer that might play a major function to improve skin survival. This mucinous layer plays an important role in tissue structural integrity and increased skin water content. 28 Indeed, these modifications are important to stimulate connective tissue synthesis in normal and photodamaged skin 29 and are involved in the wound-healing process. 30, 31 Moreover, the present study indicates that the protective effect of E2 against necrosis is associated with an accelerated reperfusion of the flap, following collateral remodeling. Doppler analysis and angiography showed that E2 improved blood perfusion, from day 4 to 8 after ischemia. In ovariectomized animals, major hemorrhages were found within the tissue and extravascular erythrocytes were most abundant in the middle zone of skin flaps, where reperfusion occurred. Transmission electron microscopy revealed vascular leakage, with obvious endothelial disjunctions responsible for erythrocyte extravasations. In E2-treated animals, erythrocytes remained intravascular, even if some endothelial cells displayed ultrastructural damages, suggesting that the increase in skin survival induced by E2 
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also benefits on vascular network preservation. This original result is in line with its antiapoptotic effect reported previously in vitro on different cultured endothelial cells 9, 32, 33 but also on the decrease of vessel permeability observed in the brain following estrogen treatment in rats. 34 E2 is known to directly modulate endothelial migration, proliferation, 8 and vascularization through induction of several growth factors, such as VEGF 35 or FGF-2. 36 Here, we found that both VEGF and FGF-2 levels were higher in E2-treated mice. These results strongly suggest that E2 probably contributes to accelerate vascular remodeling: arteriogenesis and angiogenesis. Collateral remodeling is known to be rapid in C57BL/6 mice, with functional collaterals already present 3 days after hindlimb ischemia. 37 Because this remodeling occurred rapidly and because skin is rich in anastomoses, small differences in the timing of collateral remodeling between treated and untreated C57BL/6 mice were difficult to evaluate in our model. Because arteriogenesis was shown to be reduced in BALB/c mice and delayed to days 7 to 14 after femoral occlusion, 37 skin flap necrosis was investigated in BALB/c mice (see supplemental Figure IV ). The protective effect of E2 was found to be largely decreased on this genetic background but remained significant compared to ovariectomized mice. Indeed, high rates of necrosis (more than 30%) were measured in E2-treated BALB/c mice, which developed the most extensive necrosis among all mice of strains tested. These are associated with no significant difference in blood perfusion following surgery between the 2 groups, suggesting that delayed arteriogenesis in BALB/c could have impaired the protective action of E2 in treated mice.
Recruitment of bone marrow cells has been demonstrated to be involved in neovascularization of ischemic tissues. 38, 39 Otherwise, transplantation of bone marrow from ER␣ Ϫ/Ϫ mice did not have any impact on the protective effect of E2, indicating that the protective targets of E2 are not bone marrow-derived cells. 40 All of these data suggest that, rather than neovascularization involving endothelial progenitor cells, the early collateral remodeling is critical for future survival of the skin and consequently for the protective effect by E2.
We propose the following mechanism of protection by E2 (Figure 8 ). (1) E2 modifies the structure-function characteristics of the skin, which (2) favors skin survival including dermis and vessels integrity. In the meantime, (3) collateral remodeling occurs and allows skin reperfusion. Because the vascular network is protected in E2-treated mice, reperfusion induces revascularization of the skin flap. Conversely, in the absence of E2, the vascular network is damaged, and this is followed by vessel leakage and strong damage. Thus, preservation of the vascular network associated with arteriogenesis appeared as the prominent mechanism accounting for the protective effect of E2 against ischemia-associated necrosis. In addition, E2 was reported to accelerate cutaneous wound healing through TGF-␤ secretion. 11 TGF-␤ is important at the final healing phase to resolve inflammation and reconstitute the extracellular matrix. We confirmed this effect using a TGF-␤-neutralizing antibody, which delayed wound healing.
Tamoxifen has partial agonist or antagonist estrogenic activities in different tissues 41 and has been recently shown to accelerate cutaneous wound healing. 42 We report here that tamoxifen is as efficient as E2 to prevent skin flap necrosis, providing a new perspective in patients undergoing reconstructive surgery after breast cancer. Moreover, the effects on skin structure are close to those of E2, suggesting that tamoxifen acts as an estrogen-like molecule in this tissue. Recent data showing that this selective estrogen receptor Figure 8 . Proposed mechanism of protection by E2. The 4 major vascular pedicles were sectioned during surgery, creating a severe ischemia. On day 2, E2 promotes survival of the skin as compared to untreated mice and consequently better preserves the vascular network. On days 2 to 4, collateral remodeling on the top of the flap permitted reperfusion of the quasitotal surface of the flap, thus reducing necrosis in E2-treated animals. In untreated animals, although collateral remodeling has occurred, the vascular network is damaged and leaky. Then, the reperfusion induces strong hemorrhages resulting in strong necrosis.
modulator confers estrogenic effect in various vascular systems 43, 44 are in agreement with the vascular protection evidenced in the present model.
In summary, we demonstrated here for the first time that a short administration of E2 prevents ischemia-induced skin necrosis. E2 thus delayed progression of the wavefront of ischemic cell death described by Reimer et al, 45 preserving the vascular network that facilitates reperfusion. These observational data are important for the different models of ischemia/reperfusion.
